ScriptAbility is now integrated with McKesson’s EnterpriseRx, enabling its pharmacy clients with medication adherence and safety by providing accessible prescription labels for those who are visually impaired or have limited English proficiency.
The accessible labeling solution was founded by En-Vision America, and it allows pharmacists to provide their patients with ScripTalk Talking Labels, ScriptView Large Print Labels, Dual Language/Translated Labels, Braille Labels and Controlled Substance Safety Labels.
Through this integration, pharmacists who use EnterpriseRx can pre-populate the patient information into the ScriptAbility labeling software using a barcode scan and then print the accessible label that suits their patient’s needs.
[Read more: Walmart, Sam’s Club expand En-Vision America’s ScripTalk labels]
“We applaud McKesson for facilitating this important linkage with ScriptAbility,” said David Raistrick of En-Vision America. “Each patient is unique, and their labeling needs vary. With this integration, McKesson helps to ensure that the software can provide more effective and safer access to medication information.”
“We continue to look for new ways to advance the entire landscape of pharmacy technology, which includes fostering a healthcare environment that prioritizes inclusivity and patient safety,” said Maureen Meyer, vice president of product management at McKesson.